Singapore, July 9 -- Japan's Chugai Pharmaceutical and Gero,a Singapore-based biotechnology company, have entered into a joint research and license agreement to develop novel therapies for age-related diseases.

Published by HT Digital Content Services with permission from BioSpectrum Asia....